UK-based Signifier Medical Technologies, a treatment provider for sleep disordered breathing and snoring, has partnered with Sunrise, a provider of AI-based at-home diagnostic solutions for obstructive sleep apnea, to combine Signifier’s “eXciteOSA” solution with Sunrise’s patient management portal. 

Through this partnership, healthcare providers will be able to better diagnose patients, gather patient data, and provide patients with the necessary tools for treatment. The partnership will also help Sunrise expand its geographical reach into the UK. 

Belgium-based Sunrise is a sleep-based technology company that offers at-home tests to diagnose users that have sleep apnea. The company’s at-home test uses a lightweight sensor paired with an app to measure a user’s sleep and then presents the results. Sunrise uses a sensor that is attached to a user’s chin and measures mandibular movement to provide a diagnosis in a few hours. After the diagnosis is presented to the user, they are able to consult virtually with sleep specialists to receive treatment. The company operates across Europe, Australia, and the US, and has received De Novo classification from the FDA.